Hainan Poly Pharm Co Ltd - Class A

SZSE:300630 (China)   Class A
Â¥ 12.35 (0%) May 31
17.64
P/B:
1.76
Market Cap:
Â¥ 5.58B ($ 770.42M)
Enterprise V:
Â¥ 7.76B ($ 1.07B)
Volume:
-
Avg Vol (2M):
17.16M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Hainan Poly Pharm Co Ltd ( ) from 2017 to Jun 01 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hainan Poly Pharm stock (SZSE:300630) PE ratio as of Jun 01 2024 is 17.64. More Details

Hainan Poly Pharm Co Ltd (SZSE:300630) PE Ratio (TTM) Chart

To

Hainan Poly Pharm Co Ltd (SZSE:300630) PE Ratio (TTM) Historical Data

Total 1201
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Hainan Poly Pharm PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-01 17.6 2024-03-28 25.7
2024-05-31 17.6 2024-03-27 25.4
2024-05-30 17.6 2024-03-26 25.8
2024-05-29 17.6 2024-03-25 26.3
2024-05-28 17.6 2024-03-22 27.3
2024-05-27 17.6 2024-03-21 28.3
2024-05-24 17.6 2024-03-20 28.9
2024-05-23 17.6 2024-03-19 28.7
2024-05-22 17.6 2024-03-18 29.4
2024-05-21 17.6 2024-03-15 28.7
2024-05-20 17.6 2024-03-14 27.2
2024-05-17 17.6 2024-03-13 27.5
2024-05-16 17.6 2024-03-12 27.6
2024-05-15 17.6 2024-03-11 27.3
2024-05-14 17.6 2024-03-08 26.6
2024-05-13 17.6 2024-03-07 26.2
2024-05-10 17.6 2024-03-06 27.1
2024-05-09 17.6 2024-03-05 27.2
2024-05-08 17.6 2024-03-04 28.1
2024-05-07 17.6 2024-03-01 27.2
2024-05-06 17.6 2024-02-29 27.3
2024-05-03 17.6 2024-02-28 26.4
2024-05-02 17.6 2024-02-27 27.7
2024-04-30 17.6 2024-02-26 26.9
2024-04-29 21.7 2024-02-23 27.2
2024-04-26 21.0 2024-02-22 26.9
2024-04-25 20.8 2024-02-21 26.5
2024-04-24 20.8 2024-02-20 26.9
2024-04-23 20.7 2024-02-19 26.0
2024-04-22 20.6 2024-02-16 25.3
2024-04-19 20.7 2024-02-09 25.3
2024-04-18 20.3 2024-02-08 25.3
2024-04-17 21.2 2024-02-07 24.3
2024-04-16 22.9 2024-02-06 23.8
2024-04-15 23.9 2024-02-05 21.4
2024-04-12 24.3 2024-02-02 23.1
2024-04-11 24.7 2024-02-01 24.6
2024-04-10 25.1 2024-01-31 24.4
2024-04-09 25.7 2024-01-30 25.9
2024-04-08 24.9 2024-01-29 27.4
2024-04-05 25.7 2024-01-26 27.2
2024-04-03 25.7 2024-01-25 27.6
2024-04-02 26.1 2024-01-24 26.7
2024-04-01 26.5 2024-01-23 26.6
2024-03-29 25.5 2024-01-22 26.2

Hainan Poly Pharm Co Ltd (SZSE:300630) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Hainan Poly Pharm Co Ltd is a pharmaceutical manufacturer in China. It manufactures injections, oral solid formulations, dry suspension, and other active pharmaceutical ingredients. The products offered by the company include Azithromycin for Injection, Ganciclovir Sodium for Injection. Octreotide Acetate Injection, Trimebutine Maleate tablets, Desloratadine, Trimebutine Maleate, and GANCICLOVIR among others.